MLYS
Mineralys Therapeutics, Inc.NASDAQHealthcare$26.97+4.67%ClosedMarket Cap: $1.79B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
50
Sales
55
Buy/Sell Ratio
0.91
Total Bought
$2.00
Total Sold
$27.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 02 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 19,364 | $25.50 | 760,687 |
| Thu Apr 02 | Karydas Daphne | director | Sell | 3,000 | $25.00 | 6,200 |
| Thu Apr 02 | Karydas Daphne | director | Sell | 3,000 | $12.02 | 41,000 |
| Thu Apr 02 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 453 | $27.05 | 705,051 |
| Thu Apr 02 | Congleton Jon | director, officer: Chief Executive Officer | Sell | 55,183 | $26.54 | 705,504 |
| Tue Mar 31 | RA CAPITAL MANAGEMENT, L.P. | director | Buy | 58,300 | $24.16 | 5,825,521 |
| Tue Mar 31 | RA CAPITAL MANAGEMENT, L.P. | director | Buy | 310,700 | $23.67 | 5,767,221 |
| Tue Mar 17 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 417 | $15.44 | 76,557 |
| Tue Mar 17 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 417 | $25.65 | 76,140 |
| Mon Mar 16 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 6,348 | $27.37 | 82,489 |
| Mon Mar 16 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 6,348 | $1.08 | 88,837 |
| Mon Mar 16 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 4,167 | $14.25 | 95,834 |
| Mon Mar 16 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 3,542 | $10.20 | 123,959 |
| Mon Mar 16 | Rodman David Malcom | officer: Chief Medical Officer | Sell | 10,726 | $25.91 | 79,472 |